Biktarvy

GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
BioSpace
Tue, 07/23/24 - 06:29 pm
GSK
Dovato
Gilead Sciences
Biktarvy
clinical trials
HUV
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
JNJ
GSK
ViiV
Gilead Sciences
HIV
Cabenuva
Biktarvy
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
Yahoo/Reuters
Fri, 02/24/23 - 09:08 am
GSK
HIV
ViiV Healthcare
Gilead Sciences
Cabenuva
Biktarvy
Gilead reports 'very strong quarter' despite slipping Veklury sales
Endpoints
Wed, 08/3/22 - 10:55 am
Gilead Sciences
earnings
Biktarvy
GSK to get $1.25 bln to settle HIV drug patent row with Gilead
Reuters
Wed, 02/2/22 - 11:01 am
GSK
Gilead Sciences
HIV
Biktarvy
patents
Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness
NASDAQ
Fri, 10/29/21 - 11:05 am
Gilead Sciences
Biktarvy
HIV
RWE
Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Endpoints
Mon, 03/8/21 - 11:04 am
Gilead Sciences
Biktarvy
HIV
Gilead announces new data on Biktarvy for the treatment of HIV in Black Americans
Pharmaceutical Business Review
Thu, 10/22/20 - 11:04 am
Gilead Sciences
Biktarvy
HIV
GSK's plan to take over the HIV drug market hasn't worked out
BioPharma Dive
Mon, 01/6/20 - 11:47 pm
GSK
FDA
HIV
Dovato
Biktarvy
ViiV Healthcare
Gilead Sciences
Will Its HIV Lineup Save Gilead Sciences?
Motley Fool
Mon, 11/11/19 - 07:50 pm
Gilead Sciences
HIV
Descovy
Biktarvy
Gilead Sciences Reports Improving Revenue in the 2nd Quarter
Motley Fool
Wed, 07/31/19 - 08:47 am
Gilead Sciences
earnings
Biktarvy
Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void
Fierce Pharma
Thu, 07/11/19 - 09:45 am
AbbVie
Humira
Gilead Sciences
Biktarvy
Truvada
Pfizer
Xeljanz
television ads
DTC ads
Gilead Sciences’ Biktarvy shows high efficacy in HIV-1 study
Pharmaceutical Business Review
Thu, 10/4/18 - 09:42 am
Gilead Sciences
Biktarvy
HIV-1
HIV
4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
Motley Fool
Mon, 07/16/18 - 09:21 am
HIV
Gilead Sciences
Biktarvy
GSK
Triumeq
Genvoya
Tivicay
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Yahoo/Reuters
Wed, 06/20/18 - 09:28 am
GSK
Gilead Sciences
HIV
AIDS
Dolutegravir
lamivudine
Biktarvy
GlaxoSmithKline's next-generation HIV battle against Gilead is already taking a toll on growth
Fierce Pharma
Sat, 04/28/18 - 12:13 pm
GSK
HIV
Biktarvy
Gilead Sciences
Triumeq
Tivicay
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
CP Wire
Fri, 04/27/18 - 11:39 am
Gilead Sciences
Biktarvy
HIV
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy
Fri, 04/27/18 - 09:56 am
Gilead Sciences
Biktarvy
HIV
Gilead: Did Biktarvy Kill The Sell Thesis?
Seeking Alpha
Tue, 03/27/18 - 09:54 am
Gilead Sciences
Biktarvy
HIV
Kite Pharma
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
Mon, 03/26/18 - 10:45 am
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma

Pages